Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study.

Bacić I, Druzijanić N, Karlo R, Skifić I, Jagić S.

J Exp Clin Cancer Res. 2010 Feb 12;29:12. doi: 10.1186/1756-9966-29-12.

2.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
3.

Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.

Tantivejkul K, Vucenik I, Eiseman J, Shamsuddin AM.

Breast Cancer Res Treat. 2003 Jun;79(3):301-12.

PMID:
12846414
5.

Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.

Vucenik I, Shamsuddin AM.

J Nutr. 2003 Nov;133(11 Suppl 1):3778S-3784S. Review.

6.

Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions.

Tantivejkul K, Vucenik I, Shamsuddin AM.

Anticancer Res. 2003 Sep-Oct;23(5A):3681-9.

PMID:
14666664
7.

Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.

Janus SC, Weurtz B, Ondrey FG.

Laryngoscope. 2007 Aug;117(8):1381-8.

PMID:
17607147
8.
9.
10.
11.

Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.

Groenvold M, Fayers PM, Petersen MA, Mouridsen HT.

Breast Cancer Res Treat. 2006 Aug;98(3):275-84. Epub 2006 Mar 16.

PMID:
16541325
12.
13.

Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires.

Mosconi P, Apolone G, Barni S, Secondino S, Sbanotto A, Filiberti A.

Tumori. 2002 Mar-Apr;88(2):110-6. Erratum in: Tumori 2002 Jul-Aug;88(4):352.

PMID:
12088249
14.

Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer.

Somasundar P, Riggs DR, Jackson BJ, Cunningham C, Vona-Davis L, McFadden DW.

J Surg Res. 2005 Jun 15;126(2):199-203.

PMID:
15919420
15.

Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.

Adjuvant Breast Cancer Trials Collaborative Group..

J Natl Cancer Inst. 2007 Apr 4;99(7):506-15.

PMID:
17405995
16.

[Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolerability].

Loewe-Mesch A, Kuehn JJ, Borho K, Abel U, Bauer C, Gerhard I, Schneeweiss A, Sohn C, Strowitzki T, v Hagens C.

Forsch Komplementmed. 2008 Feb;15(1):22-30. doi: 10.1159/000112860. German.

PMID:
18334811
17.

Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.

Fu M, Song Y, Wen Z, Lu X, Cui L.

Nutrients. 2016 May 12;8(5). pii: E286. doi: 10.3390/nu8050286.

18.

Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.

Schröterová L, Hasková P, Rudolf E, Cervinka M.

Oncol Rep. 2010 Mar;23(3):787-93.

PMID:
20127021
19.

Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.

Rayan G, Dawson LA, Bezjak A, Lau A, Fyles AW, Yi QL, Merante P, Vallis KA.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):154-61.

PMID:
12504048
20.

Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.

Murgić J, Soldić Z, Vrljić D, Samija I, Kirac I, Bolanca A, Kusić Z.

Coll Antropol. 2012 Dec;36(4):1335-41.

PMID:
23390830

Supplemental Content

Support Center